Parenteral ( pre-filled syringe injection) · After reconstitution1 dose (0.5ml) contains not less than 10^3 CCID 50 + not less than 10^3.7 CCID 50 + 10^3 CCID 50
Dosage form
Parenteral ( pre-filled syringe injection)
Strength
After reconstitution1 dose (0.5ml) contains not less than 10^3 CCID 50 + not less than 10^3.7 CCID 50 + 10^3 CCID 50
Manufacturer
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89, B-1330 Rixensart, Belgium